Osteoporosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on osteoporosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for osteoporosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The osteoporosis treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Drug Type: Bisphosphonates; Calcitonin; Hormone Therapy; Selective Estrogen Receptor Modulators (SERMs); Parathyroid Hormone-Related Protein (PTHrP) Analog; Rank Ligand (RANKL) Inhibitor
2) By Route Of Administration: Oral; Injectable; Other Routes
3) By Distribution Channel: Hospitals; Retail Pharmacies And Stores; Online Pharmacies
Subsegments:
1) By Bisphosphonates: Alendronate; Risedronate; Ibandronate; Zoledronic Acid
2) By Calcitonin: Salmon Calcitonin; Synthetic Calcitonin Formulations
3) By Hormone Therapy: Estrogen Replacement Therapy; Combination Hormone Therapy (Estrogen And Progesterone)
4) By Selective Estrogen Receptor Modulators (SERMs); Raloxifene; Bazedoxifene
5) By Parathyroid Hormone-Related Protein (PTHrP) Analog: PTH Analog (Teriparatide); Other PTHrP Analogues
6) By Rank Ligand (RANKL) Inhibito: Denosumab
Companies Mentioned: Pfizer Inc.; F. Hoffmann La Roche Ltd.; Merck and Co Inc.; AbbVie Inc.; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
- 1. Executive Summary
- 2. Osteoporosis Treatment Market Characteristics
- 3. Osteoporosis Treatment Market Trends And Strategies
- 4. Osteoporosis Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
- 5. Global Osteoporosis Treatment Growth Analysis And Strategic Analysis Framework
- 5.1. Global Osteoporosis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Osteoporosis Treatment Market Growth Rate Analysis
- 5.4. Global Osteoporosis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Osteoporosis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Osteoporosis Treatment Total Addressable Market (TAM)
- 6. Osteoporosis Treatment Market Segmentation
- 6.1. Global Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bisphosphonates
- Calcitonin
- Hormone Therapy
- Selective Estrogen Receptor Modulators (SERMs)
- Parathyroid Hormone-Related Protein (PTHrP) Analog
- Rank Ligand (RANKL) Inhibitor
- 6.2. Global Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Injectable
- Other Routes
- 6.3. Global Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Retail Pharmacies And Stores
- Online Pharmacies
- 6.4. Global Osteoporosis Treatment Market, Sub-Segmentation Of Bisphosphonates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Alendronate
- Risedronate
- Ibandronate
- Zoledronic Acid
- 6.5. Global Osteoporosis Treatment Market, Sub-Segmentation Of Calcitonin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Salmon Calcitonin
- Synthetic Calcitonin Formulations
- 6.6. Global Osteoporosis Treatment Market, Sub-Segmentation Of Hormone Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Estrogen Replacement Therapy
- Combination Hormone Therapy (Estrogen And Progesterone)
- 6.7. Global Osteoporosis Treatment Market, Sub-Segmentation Of Selective Estrogen Receptor Modulators (SERMs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Raloxifene
- Bazedoxifene
- 6.8. Global Osteoporosis Treatment Market, Sub-Segmentation Of Parathyroid Hormone-Related Protein (PTHrP) Analog, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- PTH Analog (Teriparatide)
- Other PTHrP Analogues
- 6.9. Global Osteoporosis Treatment Market, Sub-Segmentation Of Rank Ligand (RANKL) Inhibito, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Denosumab
- 7. Osteoporosis Treatment Market Regional And Country Analysis
- 7.1. Global Osteoporosis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Osteoporosis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Osteoporosis Treatment Market
- 8.1. Asia-Pacific Osteoporosis Treatment Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Osteoporosis Treatment Market
- 9.1. China Osteoporosis Treatment Market Overview
- 9.2. China Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Osteoporosis Treatment Market
- 10.1. India Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Osteoporosis Treatment Market
- 11.1. Japan Osteoporosis Treatment Market Overview
- 11.2. Japan Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Osteoporosis Treatment Market
- 12.1. Australia Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Osteoporosis Treatment Market
- 13.1. Indonesia Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Osteoporosis Treatment Market
- 14.1. South Korea Osteoporosis Treatment Market Overview
- 14.2. South Korea Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Osteoporosis Treatment Market
- 15.1. Western Europe Osteoporosis Treatment Market Overview
- 15.2. Western Europe Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Osteoporosis Treatment Market
- 16.1. UK Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Osteoporosis Treatment Market
- 17.1. Germany Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Osteoporosis Treatment Market
- 18.1. France Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Osteoporosis Treatment Market
- 19.1. Italy Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Osteoporosis Treatment Market
- 20.1. Spain Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Osteoporosis Treatment Market
- 21.1. Eastern Europe Osteoporosis Treatment Market Overview
- 21.2. Eastern Europe Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Osteoporosis Treatment Market
- 22.1. Russia Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Osteoporosis Treatment Market
- 23.1. North America Osteoporosis Treatment Market Overview
- 23.2. North America Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Osteoporosis Treatment Market
- 24.1. USA Osteoporosis Treatment Market Overview
- 24.2. USA Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Osteoporosis Treatment Market
- 25.1. Canada Osteoporosis Treatment Market Overview
- 25.2. Canada Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Osteoporosis Treatment Market
- 26.1. South America Osteoporosis Treatment Market Overview
- 26.2. South America Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Osteoporosis Treatment Market
- 27.1. Brazil Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Osteoporosis Treatment Market
- 28.1. Middle East Osteoporosis Treatment Market Overview
- 28.2. Middle East Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Osteoporosis Treatment Market
- 29.1. Africa Osteoporosis Treatment Market Overview
- 29.2. Africa Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Osteoporosis Treatment Market Competitive Landscape And Company Profiles
- 30.1. Osteoporosis Treatment Market Competitive Landscape
- 30.2. Osteoporosis Treatment Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck and Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 31. Osteoporosis Treatment Market Other Major And Innovative Companies
- 31.1. GlaxoSmithKline Pharmaceutical Ltd.
- 31.2. Takeda Pharmaceutical Company
- 31.3. Eli Lilly and Company
- 31.4. Amgen Inc.
- 31.5. Novo Nordisk A/S
- 31.6. Asahi Kasei Corporation
- 31.7. AstraZeneca Plc.
- 31.8. Viatris Inc.
- 31.9. Teva Pharmaceuticals Industries Ltd.
- 31.10. Daiichi Sankyo Company Ltd
- 31.11. Dr. Reddy's Laboratories
- 31.12. Gedeon Richter Plc.
- 31.13. Celltrion Inc.
- 31.14. Luye Pharma Group
- 31.15. Ligand Pharmaceuticals Incorporated
- 32. Global Osteoporosis Treatment Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Osteoporosis Treatment Market
- 34. Recent Developments In The Osteoporosis Treatment Market
- 35. Osteoporosis Treatment Market High Potential Countries, Segments and Strategies
- 35.1 Osteoporosis Treatment Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Osteoporosis Treatment Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Osteoporosis Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook